Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Ling

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Biomaterials|May 12, 2023
An electrospun macrodevice for durable encapsulation of human cells with consistent secretion of therapeutic antibodiesSachiko Imaichi-Kobayashi, Rayan Kassab, Alessandra Piersigilli, et al.
Chemistry & Biology|May 25, 2006
Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitroElena V Getmanova, Yan Chen, Laird Bloom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligandJoaquín Madrenas, Luan A Chau, Wendy A Teft, et al.
Neuroscience Letters|October 26, 2002
Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in miceSuzana Marusic, Joy S Miyashiro, John Douhan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Induction of tumor regression by administration of B7-Ig fusion proteins: mediation by type 2 CD8+ T cells and dependence on IL-4 productionNobuya Yamaguchi, Shin-ichiro Hiraoka, Takao Mukai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2AMiren L Baroja, Lalitha Vijayakrishnan, Estelle Bettelli, et al.
Frontiers in Medicine|August 2, 2021
Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type PsoriasisMartin Bauer, Edith Lackner, Peter Matzneller, et al.
Journal of Neuroimmunology|July 12, 2005
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patientsAslaug R Lorentzen, Elisabeth G Celius, Per O Ekstrøm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responsesFrann Bennett, Deborah Luxenberg, Vincent Ling, et al.
Journal of Leukocyte Biology|July 24, 2010
Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethalityErica Marchlik, Paresh Thakker, Thaddeus Carlson, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biomaterials|May 12, 2023
An electrospun macrodevice for durable encapsulation of human cells with consistent secretion of therapeutic antibodiesSachiko Imaichi-Kobayashi, Rayan Kassab, Alessandra Piersigilli, et al.
Chemistry & Biology|May 25, 2006
Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitroElena V Getmanova, Yan Chen, Laird Bloom, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligandJoaquín Madrenas, Luan A Chau, Wendy A Teft, et al.
Neuroscience Letters|October 26, 2002
Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in miceSuzana Marusic, Joy S Miyashiro, John Douhan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
Induction of tumor regression by administration of B7-Ig fusion proteins: mediation by type 2 CD8+ T cells and dependence on IL-4 productionNobuya Yamaguchi, Shin-ichiro Hiraoka, Takao Mukai, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2002
Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2AMiren L Baroja, Lalitha Vijayakrishnan, Estelle Bettelli, et al.
Frontiers in Medicine|August 2, 2021
Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type PsoriasisMartin Bauer, Edith Lackner, Peter Matzneller, et al.
Journal of Neuroimmunology|July 12, 2005
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patientsAslaug R Lorentzen, Elisabeth G Celius, Per O Ekstrøm, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2003
Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responsesFrann Bennett, Deborah Luxenberg, Vincent Ling, et al.
Journal of Leukocyte Biology|July 24, 2010
Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethalityErica Marchlik, Paresh Thakker, Thaddeus Carlson, et al.
Pageof 3